Clinical Trial Update: A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for TAK-385 in hormone treatment-naïve prostate cancer participants; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TAK-385

Snippet

Sponsor: Takeda | Conditions: Hormone Treatment-naïve Participants With Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-11-19